The aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

The aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma.

The aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37680185

about

GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression.A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors Sodium glycididazole enhances the radiosensitivity of laryngeal cancer cells through downregulation of ATM signaling pathway.aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma.

P2860

Q33733761-5A35C3B4-3D08-4338-8776-7648AB38604D Q35632953-50FF4731-58D0-4D31-B872-DEF2C19462B3 Q35793718-DB006C09-A3AC-4C32-B059-2AC9E9785CED Q36106815-6D695612-25F1-4A61-820A-BE249EA13E1C Q37688222-A3323AB9-9A05-4526-AE04-129C51FEDB24 Q37688959-8108A5D1-ACEE-4378-AADF-7B5010C2CC62 Q38818229-5185CE61-F618-4D54-8394-F29973B35BAD Q50962965-056F6178-9ACD-4D12-9014-AF9913FBAB6E

P2860

The aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37680185

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The aPKCι blocking agent ATM n ...... n of hepatocellular carcinoma.

@en

The aPKCι blocking agent ATM n ...... n of hepatocellular carcinoma.

@nl

type

label

The aPKCι blocking agent ATM n ...... n of hepatocellular carcinoma.

@en

The aPKCι blocking agent ATM n ...... n of hepatocellular carcinoma.

@nl

prefLabel

The aPKCι blocking agent ATM n ...... n of hepatocellular carcinoma.

@en

The aPKCι blocking agent ATM n ...... n of hepatocellular carcinoma.

@nl

P1433

Q37680185-4056004A-835F-4AED-9D90-0CC074934362

P1476

Q37680185-55693B86-61DD-424E-B966-8E6D42ADF31F

P2093

Q37680185-10855709-B770-478C-9485-DF5F04583325

Q37680185-21ED9EE5-D731-43CC-AA4D-FE5D5924376C

Q37680185-478458FB-0927-4C8C-A6E3-A756328F3196

Q37680185-574EB8FB-FDDF-480D-A22D-00071B8AA51C

Q37680185-7941B1F2-4766-4758-AA6B-AE06760884D9

Q37680185-8665A504-9503-40EC-93CE-92A4D70B8C07

Q37680185-952AD77F-590B-4D7A-9F76-AB767E1A0831

Q37680185-9A895BB1-2790-45A4-9036-8DC771DB5502

Q37680185-AECE1E61-DCEE-4FCA-9920-ADD6F32BE229

Q37680185-B333D068-A52F-4140-BA0B-6737D5F658A0

P2860

Q37680185-033561A5-3E7B-4DC0-AB3C-3E34D85A067D

Q37680185-076265CB-9D7A-43EA-89DE-1B03FEF42B29

Q37680185-0D50C93E-4C46-4DB1-BCDB-A69CE0DCC88D

Q37680185-0FA8E815-5760-4200-A6AB-8DB70DE28916

Q37680185-186066FA-0E4A-45DE-8091-125549A4A794

Q37680185-1D208583-2087-4955-99A9-03C0B6475603

Q37680185-2612991A-22F4-44CA-9EC3-7131734A11AD

Q37680185-28AF268A-FFD3-4C86-823D-CBADC22C968D

Q37680185-2B829B60-72DA-4FD7-8332-BCAC655609E3

Q37680185-4094600E-A803-414D-9281-7344818DB391

P304

Q37680185-F76A2CC9-32AF-41E1-BDE0-B6BB42FB341F

P31

Q37680185-96336EE1-4343-474F-ADC9-F44001A34404

P356

Q37680185-3DB72B5F-E0CB-4EBD-9FC4-8C4E35E0EA9F

P478

Q37680185-A9BB1F2C-4B3C-4849-B8AF-73F6C29E0611

P577

Q37680185-76833B77-6E03-4212-BEE4-3723851BB1B0

P5875

Q37680185-081190EF-02B9-4DB6-86E4-7817B9A3BCB1

P698

Q37680185-31D3968A-F211-4E10-BAA5-04EC76ACB6C6

P932

Q37680185-103E0760-AAF4-4C59-9A41-2DD9430C35B2

P356

P1433

Cell Death and Disease

P1476

The aPKCι blocking agent ATM n ...... n of hepatocellular carcinoma.

@en

P2093

C Q Ma

http://www.w3.org/2001/XMLSchema#string

G S Du

http://www.w3.org/2001/XMLSchema#string

J L Hu

http://www.w3.org/2001/XMLSchema#string

J M Wang

http://www.w3.org/2001/XMLSchema#string

J Zhang

http://www.w3.org/2001/XMLSchema#string

P Zhu

http://www.w3.org/2001/XMLSchema#string

Q Shen

http://www.w3.org/2001/XMLSchema#string

W P Qi

http://www.w3.org/2001/XMLSchema#string

Y Fu

http://www.w3.org/2001/XMLSchema#string

Y Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Segregation of receptor and ligand regulates activation of epithelial growth factor receptor

Epithelial-mesenchymal transitions in tumour progression

Epithelial-mesenchymal transitions in development and disease

Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms

The transcriptional repressor Snail promotes mammary tumor recurrence

Hepatocellular carcinoma

Parsing the polarity code.

Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.

Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.

Cell polarity: Par6, aPKC and cytoskeletal crosstalk.

P304

e1129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2014.91

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260997235

http://www.w3.org/2001/XMLSchema#string

P698

24651432

http://www.w3.org/2001/XMLSchema#string

P932

3973203

http://www.w3.org/2001/XMLSchema#string